Repligen (RGEN) total liabilities

Total liabilities · fiscal 2025
$843.57M

Repligen (RGEN) had total liabilities of $843.57M at the end of fiscal 2025 (December 31, 2025). That is 1.6% lower than the $856.95M of fiscal 2024. Figures as of 18 Nov 2026, 23:55 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total liabilities, fiscal 2025
$843.57M
Change on fiscal 2024
−1.6%
Growth, 5 years
+17.7% a year
Highest on record
$866.34Mfiscal 2023
Lowest on record
$151.97Mfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Repligen total liabilities, in more detail

Over the five fiscal years to 2025 total liabilities grew at a compound 17.7% a year. Across the 9 fiscal years on record (2017–2025), the highest was $866.34M in fiscal 2023 and the lowest $151.97M in fiscal 2017.

History · 9 fiscal years

Total liabilities by fiscal year

Repligen total liabilities, year by year

Repligen (RGEN) total liabilities by fiscal year
Fiscal yearTotal liabilitiesChangeYear ended
2025$843.57M 1.6% down
2024$856.95M 1.1% down
2023$866.34M 39.5% up
2022$620.90M 2.1% up
2021$608.29M 62.8% up
2020$373.74M 9.8% up
2019$340.35M 114.0% up
2018$159.05M 4.7% up
2017$151.97M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest.

How to read it

It is broader than debt: read it against total assets, and remember that for a bank or an insurer customer deposits and policy reserves are liabilities too.

Total liabilities at health care companies of similar size

Total liabilities of Repligen and comparable companies
CompanyTotal liabilitiesFiscal year
Kymera Therapeutics KYMR$163.15M2025
DaVita DVA$16.32B2025
Halozyme Therapeutics HALO$2.48B2025
Universal Health Services UHS$8.12B2025
Repligen RGEN$843.57M2025
Bio-Techne TECH$478.51M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RGEN

Repligen, figure by figure

Repligen (RGEN) overview: price, valuation and scorecardAll health care companies by market value

Repligen total liabilities: questions and answers

How large are Repligen's total liabilities?

Repligen (RGEN) had total liabilities of $843.57M at the end of fiscal 2025 (December 31, 2025). That is 1.6% lower than the $856.95M of fiscal 2024.

What is the growth rate of Repligen's total liabilities?

Over the five fiscal years to 2025 total liabilities grew at a compound 17.7% a year.

What are the highest and lowest total liabilities figures on record for Repligen?

Across the 9 fiscal years on record (2017–2025), the highest was $866.34M in fiscal 2023 and the lowest $151.97M in fiscal 2017.

How is Repligen's total liabilities calculated?

Total liabilities is everything the company owes at the fiscal year-end — borrowings, payables, deferred revenue, lease and pension obligations and the rest. For Repligen it is on record here for 9 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Repligen (RGEN) total liabilities”, data as of 18 November 2026. https://funkfolio.com/stock/RGEN/total-liabilities

Underlying data: the company's filings with the SEC and Yahoo Finance.